Eudaimonia Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $243K | Buy |
418
+13
| +3% | +$7.56K | 0.06% | 223 |
|
|
2023
Q4 | $215K | Sell |
405
-23
| -5% | -$12.2K | 0.06% | 232 |
|
|
2023
Q3 | $217K | Sell |
428
-3
| -0.7% | -$1.52K | 0.05% | 292 |
|
|
2023
Q2 | $225K | Sell |
431
-4
| -0.9% | -$2.09K | 0.05% | 300 |
|
|
2023
Q1 | $251K | Sell |
435
-14
| -3% | -$8.07K | 0.06% | 281 |
|
|
2022
Q4 | $247K | Buy |
449
+19
| +4% | +$10.5K | 0.06% | 287 |
|
|
2022
Q3 | $218K | Sell |
430
-64
| -13% | -$32.4K | 0.06% | 294 |
|
|
2022
Q2 | $268K | Buy |
494
+53
| +12% | +$28.8K | 0.05% | 315 |
|
|
2022
Q1 | $260K | Buy |
+441
| New | +$260K | 0.04% | 337 |
|
|
2021
Q3 | $290K | Sell |
507
-275
| -35% | -$157K | 0.05% | 315 |
|
|
2021
Q2 | $394K | Buy |
782
+199
| +34% | +$100K | 0.07% | 262 |
|
|
2021
Q1 | $266K | Buy |
583
+433
| +289% | +$198K | 0.06% | 289 |
|
|
2020
Q4 | $70K | Sell |
150
-386
| -72% | -$180K | 0.02% | 527 |
|
|
2020
Q3 | $237K | Buy |
536
+382
| +248% | +$169K | 0.06% | 256 |
|
|
2020
Q2 | $56K | Sell |
154
-107
| -41% | -$38.9K | 0.02% | 473 |
|
|
2020
Q1 | $74K | Buy |
+261
| New | +$74K | 0.03% | 386 |
|